Page last updated: 2024-11-02

phenobarbital and Animal Mammary Carcinoma

phenobarbital has been researched along with Animal Mammary Carcinoma in 2 studies

Phenobarbital: A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations.
phenobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and phenyl groups.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Phoon, YP1
Chivukula, IV1
Tsoi, YL1
Kanatani, S1
Uhlén, P1
Kuiper, R1
Lendahl, U1
Mesia-Vela, S1
Sanchez, RI1
Reuhl, KR1
Conney, AH1
Kauffman, FC1

Other Studies

2 other studies available for phenobarbital and Animal Mammary Carcinoma

ArticleYear
Notch activation in the mouse mammary luminal lineage leads to ductal hyperplasia and altered partitioning of luminal cell subtypes.
    Experimental cell research, 2020, 10-01, Volume: 395, Issue:1

    Topics: Animals; Cell Transformation, Neoplastic; Epithelial Cells; Female; Hyperplasia; Mammary Glands, Ani

2020
Phenobarbital treatment inhibits the formation of estradiol-dependent mammary tumors in the August-Copenhagen Irish rat.
    The Journal of pharmacology and experimental therapeutics, 2006, Volume: 317, Issue:2

    Topics: Animals; Antioxidants; Disease Models, Animal; Estradiol; Female; Liver; Mammary Glands, Animal; Mam

2006